Literature DB >> 28239819

MiR-137 and its target TGFA modulate cell growth and tumorigenesis of non-small cell lung cancer.

X Liu1, L Chen, X-D Tian, T Zhang.   

Abstract

OBJECTIVE: MiR-137 has been reported to serve as a tumor suppressor in non-small cell lung cancer (NSCLC). However, the potential mechanism remains largely unclear. The present study aimed to explore the potential molecular mechanisms by which miR-137 regulated NSCLC.
MATERIALS AND METHODS: Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to quantify the expression levels of miR-137 in NSCLC tissues and cell lines. Dual-luciferase reporter assay was employed to confirm the specificity of miR-137 target genes. An MTT assay and flow cytometry were used to determine the rates of cell proliferation and cell cycle distribution. Furthermore, the effect of miR-137 up-regulation on TGFA expression was examined by western blot.
RESULTS: miR-137 expression levels in NSCLC cell lines or tissue were significantly lower than in a normal human lung cell line or adjacent normal tissues. We further found that upregulation of miR-137 inhibited the proliferation of NSCLC cells, whereas silencing of miR-137 promoted the proliferation of NSCLC. Moreover, we identified TGFA as a direct target gene of miR-137 in NSCLC cell. Finally, Similarly, knockdown of TGFA led to the suppression of NSCLC cell proliferation.
CONCLUSIONS: Overall, our findings indicated that miR-137 served as a tumor suppressor in NSCLC and its suppressive effect is mediated by repressing TGFA expression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28239819

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  CircRTN1 acts as a miR-431-5p sponge to promote thyroid cancer progression by upregulating TGFA.

Authors:  Yu Gao; Yichun Wang; Lei Xu; Xiaoque Xie; Liyang Zhu; Fan Wang
Journal:  Hormones (Athens)       Date:  2022-07-08       Impact factor: 2.885

2.  miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.

Authors:  Jing Sun; Xin Cai; Mingo Mh Yung; Wei Zhou; Jing Li; Yi Zhang; Zhuqing Li; Stephanie S Liu; Annie N Y Cheung; Hextan Y S Ngan; Yiliang Li; Zhijun Dai; Yan Kai; Alexandros Tzatsos; Weiqun Peng; David W Chan; Wenge Zhu
Journal:  Oncogene       Date:  2018-08-30       Impact factor: 9.867

3.  HAS2-AS1 Acts as a Molecular Sponge for miR-137 and Promotes the Invasion and Migration of Glioma Cells by Targeting EZH2.

Authors:  Juntong Wang; Yuyan Zhang; Aiwu You; Jun Li; Jingshun Gu; Guomin Rao; Xuehua Ge; Kun Zhang; Haoyu Fu; Xiaohui Liu; Jianfeng Li; Qianchao Wang; Xiaotang Wu; Ling Cheng; Mengjiao Zhu; Dongchun Wang
Journal:  Cell Cycle       Date:  2020-10-16       Impact factor: 4.534

4.  Identification of a Novel Glycolysis-Related Gene Signature Correlates With the Prognosis and Therapeutic Responses in Patients With Clear Cell Renal Cell Carcinoma.

Authors:  Zhengtong Lv; Lin Qi; Xiheng Hu; Miao Mo; Huichuan Jiang; Yuan Li
Journal:  Front Oncol       Date:  2021-03-17       Impact factor: 6.244

5.  The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients.

Authors:  Zicheng Wang; Jiayi Li; Peizhi Zhang; Leizuo Zhao; Bingyin Huang; Yingkun Xu; Guangzhen Wu; Qinghua Xia
Journal:  Front Genet       Date:  2022-07-12       Impact factor: 4.772

6.  Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma.

Authors:  Chen Liu; Xuhui Zhang; Caoyang Hu; Xuezhi Liang; Xiaoming Cao; Dongwen Wang
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

7.  MiR-137-mediated negative relationship between LGR4 and RANKL modulated osteogenic differentiation of human adipose-derived mesenchymal stem cells.

Authors:  Cong Fan; Yulong Li
Journal:  Genet Mol Biol       Date:  2022-09-19       Impact factor: 2.087

8.  MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2.

Authors:  Jingshun Gu; Juntong Wang; Aiwu You; Jun Li; Yuyan Zhang; Guomin Rao; Xuehua Ge; Kun Zhang; Xuan Liu; Dongchun Wang
Journal:  Genes Genomics       Date:  2021-06-23       Impact factor: 1.839

9.  A NOTCH1/LSD1/BMP2 co-regulatory network mediated by miR-137 negatively regulates osteogenesis of human adipose-derived stem cells.

Authors:  Cong Fan; Xiaohan Ma; Yuejun Wang; Longwei Lv; Yuan Zhu; Hao Liu; Yunsong Liu
Journal:  Stem Cell Res Ther       Date:  2021-07-22       Impact factor: 6.832

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.